Claudia Ordonez - Net Worth and Insider Trading

Claudia Ordonez Net Worth

The estimated net worth of Claudia Ordonez is at least $0 dollars as of 2024-11-13. Claudia Ordonez is the Chief Medical Officer of Keros Therapeutics Inc and owns about 0 shares of Keros Therapeutics Inc (KROS) stock worth over $0. Details can be seen in Claudia Ordonez's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Claudia Ordonez has not made any transactions after 2021-06-11 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Claudia Ordonez

To

Claudia Ordonez Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Claudia Ordonez owns 1 companies in total, including Keros Therapeutics Inc (KROS) .

Click here to see the complete history of Claudia Ordonez’s form 4 insider trades.

Insider Ownership Summary of Claudia Ordonez

Ticker Comapny Transaction Date Type of Owner
KROS Keros Therapeutics Inc 2021-06-11 Chief Medical Officer

Claudia Ordonez Latest Holdings Summary

Claudia Ordonez currently owns a total of 1 stock. Claudia Ordonez owns 0 shares of Keros Therapeutics Inc (KROS) as of June 11, 2021, with a value of $0.

Latest Holdings of Claudia Ordonez

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
KROS Keros Therapeutics Inc 2021-06-11 0 64.80 0

Holding Weightings of Claudia Ordonez


Claudia Ordonez Form 4 Trading Tracker

According to the SEC Form 4 filings, Claudia Ordonez has made a total of 4 transactions in Keros Therapeutics Inc (KROS) over the past 5 years, including 0 buys and 4 sells. The most-recent trade in Keros Therapeutics Inc is the sale of 1,000 shares on June 11, 2021, which brought Claudia Ordonez around $50,990.

Insider Trading History of Claudia Ordonez

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Claudia Ordonez Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Claudia Ordonez Ownership Network

Ownership Network List of Claudia Ordonez

No Data

Ownership Network Relation of Claudia Ordonez

Insider Network Chart

Claudia Ordonez Owned Company Details

What does Keros Therapeutics Inc do?

Who are the key executives at Keros Therapeutics Inc?

Claudia Ordonez is the Chief Medical Officer of Keros Therapeutics Inc. Other key executives at Keros Therapeutics Inc include Chief Financial Officer Keith Regnante , Chief Scientific Officer Jennifer Lachey , and Chief Operating Officer Christopher Rovaldi .

Keros Therapeutics Inc (KROS) Insider Trades Summary

Over the past 18 months, Claudia Ordonez made no insider transaction in Keros Therapeutics Inc (KROS). Other recent insider transactions involving Keros Therapeutics Inc (KROS) include a net sale of 80,000 shares made by Keith Regnante , a net sale of 250,000 shares made by Orbimed Advisors Llc , and a net sale of 250,000 shares made by Carl L Gordon .

In summary, during the past 3 months, insiders sold 0 shares of Keros Therapeutics Inc (KROS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 580,000 shares of Keros Therapeutics Inc (KROS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 580,000 shares.

Keros Therapeutics Inc (KROS)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Keros Therapeutics Inc Insider Transactions

No Available Data

Claudia Ordonez Mailing Address

Above is the net worth, insider trading, and ownership report for Claudia Ordonez. You might contact Claudia Ordonez via mailing address: C/o Keros Therapeutics, Inc., 99 Hayden Avenue, Suite 120, Building E, Lexington Ma 02421.